EDGAR Filing Documents for 0001104659-19-023074

Form 8-K - Current report:

SEC Accession No. 0001104659-19-023074

Filing Date

2019-04-23

Accepted

2019-04-23 16:01:01

Documents

Period of Report

2019-04-19

Items

Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a19-8638_18k.htm	8-K	24140
2	EX-16.1	a19-8638_1ex16d1.htm	EX-16.1	5800
	Complete submission text file	0001104659-19-023074.txt		31220

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 19761584
SIC: 2834 Pharmaceutical Preparations